APA

Urbinati G., de Waziers I., Slamiç M., Foussignière T., Ali H. M., Desmaële D., Couvreur P. & Massaad-Massade L. (20160330). Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. : Molecular therapy. Nucleic acids.

Chicago

Urbinati Giorgia, de Waziers Isabelle, Slamiç Mateja, Foussignière Tobias, Ali Hafiz M, Desmaële Didier, Couvreur Patrick and Massaad-Massade Liliane. 20160330. Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. : Molecular therapy. Nucleic acids.

Harvard

Urbinati G., de Waziers I., Slamiç M., Foussignière T., Ali H. M., Desmaële D., Couvreur P. and Massaad-Massade L. (20160330). Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. : Molecular therapy. Nucleic acids.

MLA

Urbinati Giorgia, de Waziers Isabelle, Slamiç Mateja, Foussignière Tobias, Ali Hafiz M, Desmaële Didier, Couvreur Patrick and Massaad-Massade Liliane. Knocking Down TMPRSS2-ERG Fusion Oncogene by siRNA Could be an Alternative Treatment to Flutamide. : Molecular therapy. Nucleic acids. 20160330.